NYU Langone Health institute receives $31M to study aging, vascular risks
By
Kristen Fischer
Apr 15, 2024
The National Institutes of Health has awarded Optimal Aging Institute at NYU Langone Health $31 million for a 10-university cohort to study how vascular risk factors contribute to dementia and other age-related...
Complex medication regimens may be risky for dementia patients at home, study finds
By
John Roszkowski
Mar 26, 2024
Complex medication regimens may be risky and burdensome for community-dwelling older adults suffering from dementia or mild cognitive impairment. Providers should look for ways to reduce overprescribing...
Pandemic lessons learned need to apply to future dementia care in nursing homes: editorial
By
Kristen Fischer
Feb 02, 2024
An editorial in response to a 2023 study about caring for people with dementia during the pandemic highlights some of the ongoing issues in nursing home care quality that became prominent during the outbreak...
Cirrhosis could be culprit in 1 of 10 dementia diagnoses, research finds
By
Kristen Fischer
Feb 01, 2024
Veterans in whom dementia is diagnosed may not have a lifelong disease at all. Instead, they may have a reversible cognitive decline caused by advanced liver disease, according to a study published Wednesday...
Living with dementia: ‘Nothing about us without us’
By
Charles de Vilmorin
Feb 29, 2024
We can talk endlessly about people living with dementia, but the conversation only becomes meaningful when they are active participants in the conversation. During the recent 2024 Validation World...
Report: Caregivers, healthcare workers struggle to navigate dementia care
By
Kristen Fischer
Mar 21, 2024
People caring for those with dementia — who include family members and healthcare workers — say it’s hard to navigate the disease within the US health system, according to the Alzheimer’s Association...
Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Race, ethnicity help determine which controllable risk factors for dementia have biggest impacts
By
Kristen Fischer
Jan 18, 2024
Controllable risk factors that factor into Alzheimer’s or dementia cases play varying roles based on someone’s race and ethnicity, a new study shows.